Sign Up to like & get
recommendations!
1
Published in 2019 at "Journal of immunological methods"
DOI: 10.1016/j.jim.2019.04.011
Abstract: Polyclonal T regulatory cells (Treg - CD4+CD25+CD127lowFoxp3+) are used in several protocols for the treatment of type 1 diabetes (T1D), multiple sclerosis and graft-versus host disease in clinical trials. However, general opinion is that autoantigen-specific…
read more here.
Keywords:
insulin;
insulin specific;
regulatory cells;
specific treg ... See more keywords